es the autopsy prevalence of benign prostatic hyperplasia. Prostate. 1990:17(3):241-6. Public Companies Mentioned in this Report: Astellas Pharma (ALPMY — NR - $15.00) Eli Lilly (LLY — NR - $78.60) Merck & Co (MRK -NR-$54.54) Pfizer Inc. (PFE -NR-$36.13) Johnson & Johnson. (JNJ -NR-$130.41) 24 E